Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC (NCT05464082)
Towards Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of Triple Negative Breast Cancer
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective phase 2 study to use Functional Precision Oncology (FPO) to predict, prevent and treat early metastatic recurrence in subjects with HR-low/Her2 negative or triple negative breast cancer.
Who can join: Review the eligibility criteria below.
Location: Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
Age range: 18 Years
🧪 Interventions in This Study
- Functional Precision Oncology (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
📞 Contact the Study Coordinator
Phone: (801) 585-0571
Email: janna.espinosa@hci.utah.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer Recurrent
- aPBI Re-irradiation — Lebanon, New Hampshire
Explore by condition: All Breast Cancer Recurrent clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.